XSTO
SIMRIS B
Market cap17mUSD
Oct 09, Last price
0.11SEK
1D
3.72%
1Q
33.69%
Jan 2017
-99.25%
IPO
-99.35%
Name
Simris Group AB
Chart & performance
P/E
—
P/S
93.19
EPS
—
Div yield, %
—
Shrs. gr., 5y
49.90%
Rev. gr., 5y
-5.70%
Revenues
2m
-44.12%
Net income
-27m
L-22.52%
CFO
-16m
L-10.94%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating both within Sweden and across global markets, Simris Alg AB (publ) specializes in the production and sale of nutritional supplements and food products derived from algae. Its product portfolio includes Simris Algae Omega-3, a unique plant-derived marine omega-3 supplement providing both EPA and DHA. Additionally, under its 'Simris Select' brand, the company provides a range of other algae-based items like premium chlorella, spirulina sprinkles, invigorating astaxanthin, and various algae teas such as 'flower power' and 'sun candy'. Established in 2010, the firm maintains its main office in Hammenhög, Sweden.
Key people
Johan Jorgensen
Chairman of the Board · since 2019
Carmen Koncut Peterson
Operations Director · since 2017
Maria Frisk
Global Sales Director, Commercial Director · since 2017
Nils Andersson
Director · since 2019
Anders Frostenson
Director · since 2019
Fredrika Gullfot
Chief Executive Officer, Director · since 2017
Headquarters & legal address
Herrestadsvägen 24A
HAMMENHÖG, M 276 50
SE
HAMMENHÖG, M 276 50
SE
Previous name
Simris Alg AB
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||